SPECT/CT与平面闪烁显像计算肝90Y放射栓塞肺分流分数的临床与剂量学意义
该回顾性研究纳入36例平面肺分流分数(LSF)>15%的患者,比较平面闪烁显像与SPECT/CT计算的LSF及剂量差异。结果显示平面LSF均值25.1%显著高于SPECT/CT的16.0%(p<.001),导致肺剂量高估、肝灌注剂量低估,部分患者因此接受了不必要的分流减少操作或剂量降低。建议高LSF患者放射栓塞前采用SPECT/CT计算LSF。
要点
- 平面闪烁显像计算的LSF显著高于SPECT/CT,可能高估肺剂量并低估肝剂量。
- 高LSF患者若仅依据平面结果,可能被错误排除 upfront 放射栓塞或进行剂量降低。
- BMI≥26、肿瘤最大径<9cm及左肝动脉注射时两种方法LSF差异更大。
核心结论
- 平面闪烁显像计算的LSF高于SPECT/CT,可能导致不必要的分流减少操作和处方剂量降低。
研究设计与样本
- 回顾性研究,纳入36例(男29例,女7例,平均年龄62.4±9.8岁)99mTc-MAA平面闪烁显像计划肝放射栓塞且平面LSF>15%并同期行SPECT/CT的患者。
- SPECT/CT LSF通过自动生成肺和肝脏容积ROI并手动调整后回顾性计算,总肺和灌注肝剂量采用医学内照射剂量模型计算。
- 平面与SPECT/CT数据比较采用Mann-Whitney U检验,LSF差异相关因素采用多变量回归分析。
诊断标准与关键数值
- 平面LSF均值25.1%±11.6%,SPECT/CT LSF均值16.0%±9.3%(p<.001)。
- 平面LSF对应肺剂量均值18.8±8.0 Gy,SPECT/CT LSF对应12.3±7.2 Gy(p<.001)。
- 平面LSF对应灌注肝剂量均值92.9±36.1 Gy,SPECT/CT LSF对应102.7±39.1 Gy(p<.001)。
- LSF差异较大与BMI≥26(p=.02)、肿瘤最大径<9cm(p=.05)、左肝动脉注射(p=.02)相关。
- 14例因平面LSF>20%未行 upfront 放射栓塞者中,5例SPECT/CT LSF<20%可符合 upfront 条件;29例治疗者中7例基于平面LSF降低处方剂量,其中6例用SPECT/CT LSF可符合标准剂量。
临床应用与阅片要点
- 对计划90Y放射栓塞且平面LSF较高的患者,建议补充SPECT/CT计算LSF以优化患者筛选和剂量决策。
- 报告LSF时应注明计算方法(平面或SPECT/CT),避免因方法差异导致临床决策偏差。
- BMI≥26、肿瘤最大径<9cm或左肝动脉注射的患者,平面与SPECT/CT LSF差异可能更大,需警惕。
局限性
- 回顾性单中心设计,样本量36例,结论需更大样本验证。
- SPECT/CT LSF为回顾性计算,非前瞻性临床报告值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Accurate assessment of hepatopulmonary shunting, typically performed by planar scintigraphy, is critical in planning 90Y radioembolization. High lung shunt fractions (LSFs) may alter treatment. OBJECTIVE. The purpose of this study is to compare LSFs calculated from planar scintigraphy versus SPECT/CT in patients with high planar LSFs (> 15%) and to describe the potential clinical and dosimetric implications of SPECT/CT LSF calculations. METHODS. This retrospective study included 36 patients (29 men and seven women; mean age, 62.4 ± 9.8 [SD] years) who underwent 99mTc-macroaggregated albumin (MAA) planar scintigraphy for planning hepatic radioembolization, had a planar LSF greater than 15%, and underwent concurrent SPECT/CT. Clinically reported planar LSFs were recorded. SPECT/CT LSFs were retrospectively calculated using automatically generated volumetric ROIs around the lungs and liver with subsequent manual adjustments. Total lung and perfused liver doses were calculated using a medical internal radiation dose model. Values derived from planar and SPECT/CT data were compared using Mann-Whitney U tests. Multivariable regression analysis was performed of factors associated with the discrepancy in LSF between the techniques. RESULTS. Mean planar LSF was 25.1% ± 11.6%, and mean SPECT/CT LSF was 16.0% ± 9.3% (p < .001). Mean lung dose was 18.8 ± 8.0 Gy for planar LSF versus 12.3 ± 7.2 Gy for SPECT/CT LSF (p < .001). Mean perfused liver dose was 92.9 ± 36.1 Gy using planar LSF versus 102.7 ± 39.1 Gy using SPECT/CT LSF (p < .001). In multivariable analysis, a larger discrepancy in LSF between planar scintigraphy and SPECT/CT was associated with a body mass index (weight in kilograms divided by the square of height in meters) of 26 or higher (p = .02), maximum tumor size of less than 9 cm (p = .05), and left hepatic intraarterial injection (p = .02). Fourteen of 36 patients did not undergo upfront radioembolization due to a planar LSF greater than 20% and instead underwent shunt-reducing embolization with subsequent radioembolization (n = 7), transarterial chemoembolization (n = 5), or no treatment (n = 2). Five of these 14 patients had a SPECT/CT LSF of less than 20% and would have been eligible for upfront radioembolization based on SPECT/CT LSF. Seven of 29 patients treated with radioembolization underwent prescribed dose reductions based on planar LSF; six of these patients would have qualified for standard radioembolization without dose reduction using SPECT/CT LSF. CONCLUSION. Planar scintigraphy yields greater LSFs compared with SPECT/CT, possibly leading to unnecessary shunt-reducing procedures and prescribed dose reductions. CLINICAL IMPACT. SPECT/CT should be considered for clinical LSF calculations before radioembolization in patients with high LSFs.
引用
- Struycken L, Patel M, Kuo P, et al. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic 90Y Radioembolization Using SPECT/CT Versus Planar Scintigraphy. AJR Am J Roentgenol. 2021. PMID: 34704460. doi:10.2214/AJR.21.26663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。